Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis. [PDF]
Lin CS, Hsu TW, Lee HL, Kao SH.
europepmc +1 more source
Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]
Hisada Y, Mackman N.
europepmc +1 more source
The role of suPAR and related proteins in kidney, heart diseases, and diabetes. [PDF]
Reiser J, Hayek SS, Sever S.
europepmc +1 more source
Leptospira glyceraldehyde-3-phosphate dehydrogenase (LiGAPDH): a cell-surface plasminogen binding protein. [PDF]
de Souza MCL +4 more
europepmc +1 more source
The Role of Extracellular Proteases and Extracellular Matrix Remodeling in the Pre-Metastatic Niche. [PDF]
Okura GC, Bharadwaj AG, Waisman DM.
europepmc +1 more source
The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. [PDF]
Iftikhar A, Mahmood N, Rabbani SA.
europepmc +1 more source
From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer. [PDF]
Badukle H +8 more
europepmc +1 more source
Pathophysiology of chronic subdural hematoma-new insights. [PDF]
Trieu M, Thomas AJ.
europepmc +1 more source
The Plasminogen Activation System in the Central Nervous System: Implications for Epilepsy and Neuropsychiatric Disorders. [PDF]
Suleymanova E, Karan A.
europepmc +1 more source
Prognostic biomarkers in oral squamous cell carcinoma: current evidence and future directions. [PDF]
Brockmeyer P.
europepmc +1 more source

